肝癌超声诊断与治疗现状  

Diagnosis and Therapy of Hepatocellular Carcinoma ith Ultrasound: Current Status

作　　者：王学梅[1] 周旭[1] 

机构地区：[1]中国医科大学附属第一临床学院超声中心

出　　处：《当代医学》2002年第1期64-66,共3页Contemporary Medicine

摘　　要：二维超声是肝癌诊断的基础,彩色多普勒技术和超声造影是肝癌血流检测的重要方法,二维超声与彩超等多种超声技术联合检测是提高肝癌诊断水平的关键。介入性超声细胞学和组织学检查是肝癌,尤其小肝癌定性诊断的可靠方法。介入性超声治疗使非手术肝癌原位灭活成为可能,高强度聚焦超声治疗开辟了无创性肝癌治疗的新途径。Two-dimensional sonography is the basis of diagnosing hepatocellular carcinoma (HCC). Color Doppler and contrast-enhanced ultrasound (US) play an important role in detecting blood supply of HCC. Combining sonogram to color Doppler and other techniques can improve diagnosis of HCC. As to determine HCC. especially small HCC. interventional technique provides a reliable approach with cytological and histological examinations guided by US. Interventional US therapy can kill HCC completely in situ without operation, and high intensity focused ultrasound (HIFU) also bring us a new way in HCC administrations, which is non-invasive to patient.

关 键 词：肝癌 二维超声 彩超 介入性超声 诊断 治疗 

分 类 号：R735.7[医药卫生—肿瘤]